Pailloux et al.
mL/50 mL). The aqueous phase was separated and extracted with
CH2Cl2 (3 × 10 mL) and the combined organic phases were dried
over MgSO4. The filtered organic phase was evaporated leaving a
white solid that was further purified by column chromatography
with EtOAc/hexane (1:1) as initial eluant followed by pure EtOAc.
The N-oxide 14 was isolated as a white solid. Yield: 0.31 g, 50%.
Mp 164-166 °C. 1H NMR (500 MHz, DMSO-d6): δ 2.77 (s, 3H),
6.17 (s, 1H), 7.35 (s, 4H), 7.80 (m, 6H), 7.90 (m, 9H), 8.00 (d, J
) 7.0 Hz, 2H), 8.12 (d, J ) 7.0 Hz, 2H). 13C{1H} (62.5 MHz,
DMSO-d6): δ 17.7, 52.4, 124.3, 124.6, 125.7, 126.7, 128.3, 128.7,
129.2, 130.0, 141.5, 142.7, 145.3, 147.5, 166.28. IR (KBr, cm-1):
1681 (νco). HRMS: found 514.2130 (M + H+). C33H28N3O3
requires 514.2131. Solubility: CH2Cl2 (v. sol.), MeOH (sol.),
EtOAc (sol.), hexane (insol.).
General Oxidation Procedure. A sample of 1 or 2 (1 equiv)
was dissolved in CH2Cl2 (10 mL) and m-chloroperbenzoic acid
(0.8-5 equiv) was added with stirring. The mixture was then
refluxed overnight. The resulting mixture was quenched with
aqueous saturated NaHCO3 solution and the aqueous phase was
extracted with CH2Cl2. Three spots were typically observed by TLC
and the CH2Cl2 solution containing the products was chromato-
graphed on silica gel (4 cm × 30 cm) with ethyl acetate as the
eluant. Variations in the oxidation and purification procedures led
to optimized yields for 5, 7, 9, and 11 from 1 and 6, 8, 10, and 12
from 2. Details of these procedures are presented in the Supporting
Information.
124.2, 124.7, 125.0, 126.7-129.5, 142.6, 146.8, 148.6, 168.1.
HRMS: found 319.1443 (M + H+). C20H19N2O2 requires 319.1447.
2-Hydroxy-2-(1-oxypyridin-2-yl)-N,N-diphenylacetamide (11).
1H NMR (250 MHz, CDCl3): δ 4.8 (s, 1H), 5.30 (s, 1H), 7.00 (d,
J ) 5.7 Hz, 1H), 7.05 (t, J ) 6.7 Hz, 1H), 7.10 (t, J ) 7.2 Hz,
1H), 7.15-7.40 (m, 10 H), 8.12 (d, J ) 6.0 Hz, 1H). 13C{1H} NMR
(62.5 MHz, DMSO-d6): δ 67.5, 123.9, 124.7, 125.1, 126.9, 127.5,
128.8, 138.2, 142.9, 150.9, 168.6. HRMS: found 321.1213 (M +
H+). C19H17N2O3 requires 321.1239.
2-Hydroxy-2-(6-methyl-1-oxypyridin-2-yl)-N,N-diphenylace-
tamide (12). 1H NMR (250 MHz, CDCl3): δ 2.38 (s, 3H), 5.28 (s,
1H), 6.75 (d, J ) 7.8 Hz, 1H), 6.85 (t, J ) 7.8 Hz, 1H), 7.10 (d,
J ) 8.0 Hz, 1H), 7.15-7.50 (m, 10H). 13C{1H} NMR (62.5 MHz,
CDCl3): δ 17.6, 61.9, 123.5, 124.5, 125.1, 125-130, 148.1, 149.0,
170.0. HRMS: found 335.1389 (M + H+). C20H18N2O3 requires
335.1396.
Electronic Structure Calculations. The energy change for the
gas-phase reaction AH f A- + H+ provides a measure of the
intrinsic acidity of the AH proton. ∆E values, E(A-) + E(H+) -
E(AH), were calculated for selected model compounds with the
NWChem program,50 using second-order Mo¨ller-Plesset perturba-
tion theory (MP2).51 Calculations were performed with the cor-
relation consistent aug-cc-pVDZ basis set,52 including all electrons
in the correlation treatment.
Acknowledgment is made to the U.S. Department of Energy
(DOE), Chemical Sciences, Geosciences and Biosciences Office,
Office of Basic Energy Sciences (Grant DE-FG02-03ER15419)
for financial support of this work (R.T.P.) and the DOE,
Environmental Management Science Program, Office of Science
(73759) (B.P.H.). Calculations were performed with the Mo-
lecular Science Computing Facility (MSCF) in the William R.
Wiley Environmental Molecular Sciences Laboratory, a national
scientific user facility sponsored by the DOE’s Office of
Biological and Environmental Research. We thank Dr. S.-J. Kim
for his initial experimental contributions to this study.
Selected Characterization Data for Oxidation Products:
2-Oxo-N,N-diphenyl-2-(pyridin-2-yl)acetamide (5). 1H NMR (250
MHz, CDCl3): δ 7.10-7.50 (m, 11H), 7.65-7.85 (m, 2H), 8.75
(d,d, J ) 4.0, 0.8 Hz, 1H). 13C{1H} NMR (62.5 MHz, CDCl3): δ
123.7, 126.4, 127.3, 128.3, 128.8, 129.5, 129.6, 130.0, 137.5, 140.8,
141.6, 150.2, 151.9, 167.8, 191.0. HRMS: found 303.1099 (M +
H+). C19H15N2O2 requires 303.1134.
2-Oxo-N,N-diphenyl-2-(6-methylpyridin-2-yl)acetamide (6).
1H NMR (250 MHz, CDCl3): δ 2.15 (s, 3H), 6.70-7.30 (m, 13H).
13C{1H} NMR (62.5 MHz, CDCl3): δ 24.2, 120.0, 125.8, 126.6,
127.2, 127.9, 128.8, 128.9, 129.1, 136.8, 140.2, 141.1, 150.6, 158.4,
167.5, 190.8. HRMS: found 317.1264 (M + H+). C20H17N2O2
requires 317.1290.
Supporting Information Available: Experimental details for
the formation and characterization of 4-11, detailed data from the
X-ray crystallographic structure determinations, and crystallographic
information (CIF). This material is available free of charge via the
1
2-Hydroxy-N,N-dphenyl-2-(pyridin-2-yl)acaetamide (7). H
NMR (250 MHz, CDCl3): δ 4.65 (s, 1H), 5.35 (s, 1H), 6.80 (d, J
) 8.6 Hz, 1H), 6.95 (s, 1H), 7.10 (d,d, J ) 4.0, 1.1 Hz, 1H), 7.2-
7.4 (m, 9H), 7.45 (d,d, J ) 7.8, 1.8 Hz, 1H), 8.50 (m, J ) 4.8, J
) 2.6, 1.8, J ) 0.9 Hz, 1H). 13C{1H} NMR (62.5 MHz, CDCl3):
δ 73.3, 122.9, 123.3, 128.4, 128.6, 129.4, 137.0, 150.0, 158.0, 172.6.
HRMS: found 305.1292 (M + H+). C19H17N2O2 requires 305.1290.
2-Hydroxy-N,N-diphenyl-2-(6-methylpyridin-2-yl)aceta-
JO701408Y
(50) (a) Straatsma, T. P.; Apra`, E.; Windus, T. L.; Bylaska, E. J.; de
Jong, W.; Hirata, S.; Valiev, M.; Hackler, M. T.; Pollack, L.; Harrison, R.
J.; Dupuis, M.; Smith, D. M. A.; Nieplocha, J.; Tipparaju, V.; Krishnan,
M.; Auer, A. A.; Brown, E.; Cisneros, G.; Fann, G. I.; Fruchtl, H.; Garza,
J.; Hirao, K.; Kendall, R.; Nichols, J.; Tsemekhman, K.; Wolinski, K.;
Anchell, J.; Bernholdt, D.; Borowski, P.; Clark, T.; Clerc, D.; Dachsel, H.;
Deegan, M.; Dyall, K.; Elwood, D.; Glendening, E.; Gutowski, M.; Hess,
A.; Jaffe, J.; Johnson, B.; Ju, J.; Kobayashi, R.; Kutteh, R.; Lin, Z.;
Littlefield, R.; Long, X.; Meng, B.; Nakajima, T.; Niu, S.; Rosing, M.;
Sandrone, G.; Stave, M.; Taylor, H.; Thomas, G.; van Lenthe, J.; Wong,
A.; Zhang, Z. NWChem, A Computational Chemistry Package for Parallel
Computers, Version 4.6; Pacific Northwest National Laboratory: Richland,
WA, 2004. (b) Kendall, R. A.; Apra`, E.; Bernholdt, D. E.; Bylaska, E. J.;
Dupuis, M.; Fann, G. I.; Harrison, R. J.; Ju, J.; Nichols, J. A.; Nieplocha,
J.; Straatsma, T. P.; Windus, T. L.; Wong, A. T. Comput. Phys. Commun.
2000, 128, 260-283.
1
mide (8). H NMR (250 MHz, CDCl3): δ 2.50 (s, 3H), 5.40 (s,
1H), 6.75 (d, J ) 7.7 Hz, 1H), 7.00 (d, J ) 7.7 Hz, 1H), 7.10-
7.35 (m, 10H), 7.4 (d, d, J ) 7.7 Hz, 1H), 13C{1H} NMR (62.5
MHz, CDCl3): δ 24.2, 73.0, 119.1, 122.4, 127.6-130.1, 136.8,
157.2, 158.0, 172.5. HRMS: found 319.1446 [M + H+]. C20H19N2O2
requires 319.1447.
2-(1-Oxy-pyridin-2-yl)-N,N-diphenylacetamide (9). 1H NMR
(250 MHz, CDCl3): δ 3.80 (s, 2H), 7.15-7.50 (m, 13H), 8.25 (d,
d, J ) 7.5, 4.2 Hz, 1H). 13C{1H} NMR (62.5 MHz, CDCl3): δ
37.9, 124.2, 125.0, 126.1, 127.3, 127.7, 128.4, 129.4, 138.8, 142.4,
147.0, 167.7. HRMS: found 305.1291 (M + H+). C19H17N2O2
requires 305.1290.
2-(6-Methyl-1-oxypyridin-2-yl)-N,N-diphenylacetamide (10).
1H NMR (250 MHz, CDCl3): δ 2.50 (s, 3H), 3.80 (s, 2H), 6.80-
7.60 (m, 13H). 13C{1H} NMR (62.5 MHz, CDCl3): δ 18.0, 38.6,
(51) Moller, C.; Plesset, M. S. Phys. ReV. 1934, 46, 618.
(52) (a) Dunning, T. H., Jr. J. Chem. Phys. 1989, 90, 1007. (b) Kendall,
R. A.; Dunning, T. H., Jr.; Harrison, R. J. J. Chem. Phys. 1992, 96, 6796.
9202 J. Org. Chem., Vol. 72, No. 24, 2007